FRATER RAZES: Pioneering Pharmaceutical Excellence in Algeria’s Industry

BY: Hana Saada

ALGIERS, August 14, 2023 – Founded by Dr. Abdelhamid Cherfaoui, the FRATER RAZES Laboratories Group stands as a trailblazer in Algeria’s pharmaceutical sector. Recognized as one of the first laboratories to venture into the medicine market within the country, FRATER RAZES has emerged as a leader in the Algerian pharmaceutical industry, propelled by its commitment to autonomy and the superior quality of its solutions.

Algeria’s FRATER RAZES Laboratory Achieves National Self-Sufficiency with Innovative Anticoagulant Production

The FRATER RAZES laboratory has emerged as a beacon of success in the Algerian pharmaceutical industry, marking a significant milestone by producing an anticoagulant derived from living cells. This achievement has propelled the nation towards achieving self-sufficiency in this vital medication after two decades of dependence on imports. Notably, the laboratory’s proactive response to the COVID-19 pandemic, including the creation of the groundbreaking biological anticoagulant substitute “Vaginox,” has solidified its role in securing the nation’s healthcare needs during critical times.

Unyielding Leadership: FRATER RAZES Lab’s Vital Role in Crafting 7 Essential COVID-19 Medicines Amid Global Scarcity, Spearheaded by Salah Eddine Khaled

Under the visionary leadership of Salah Eddine Khaled, the general strategy official at the FRATER RAZES laboratory, the institution played a pivotal role in the battle against the Covid-19 pandemic. Despite global scarcity of medicines, the laboratory stood firm in its commitment to provide essential medications, including its contribution to the production of 7 out of the 8 medicines employed in COVID-19 treatment protocols.

Hamza Mansour, the director of the production unit at the laboratory, underscored the adherence to international standards in the facility’s operations. Comprising five production poles, the complex boasts a wide array of capabilities. The injected materials pole, equipped with five units, maintains an annual production rate of 150 units. The technology pole, consisting of three units, ensures the manufacture of 50 million syringes a year. Further, the specialized dry materials pole operates two units that yield 50 million cans per year.

The fourth pole, dedicated to the creation of food supplements, generates 40 nutritional products, while the fifth pole oversees quality control across an expansive area of 2500 square meters. Lakoui Aisha, the official in charge of the laboratory’s regulatory affairs unit, elucidated the comprehensive scope of the pharmaceutical complex. It encompasses 14 medicinal and therapeutic families, offering solutions for chronic conditions like heart diseases, arterial ailments, and cancers. Additionally, the laboratory boasts 172 medicinal products, with some awaiting licensure and others progressing through the development pipeline.

Cutting-Edge Quality Standards

FRATER RAZES Laboratories adhere to a system that prioritizes good manufacturing practices and quality management, in line with ISO 9001:2015 standards. The group’s unwavering dedication to quality assurance is demonstrated through their meticulous product quality control procedures, which align with international norms such as the ICH, European Pharmacopoeia, and British and American standards.

The company has obtained various accreditations from national and international audits, endorsed by the regulatory authorities, the Ministry of Pharmaceutical Industry, and the National Agency for Pharmaceutical Products.

A Commitment to Standards & Procedures

FRATER RAZES Laboratories are dedicated to maintaining a leading-edge position through technological advancements. The group’s commitment to adhering to norms is unwavering, as they consider it a cornerstone that cannot be compromised when striving for continuous excellence on an international scale.

To ensure this, the laboratories have implemented a multitude of stringent procedures that underpin the quality and reliability of their products. With over 800 internal control procedures and an annual audit by the National Agency for Pharmaceutical Products, the group’s commitment to quality assurance is resolute.

The state-of-the-art industrial tools used for production adhere to Good Manufacturing Practices (GMP) standards, originating from Northern Europe. Moreover, the laboratories meticulously verify the GMP certifications of their suppliers. FRATER RAZES holds the ISO 9001:2015 certification, a globally recognized standard for quality management.

Specialties that Span Decades

With three decades of experience, FRATER RAZES Laboratories possess remarkable expertise that covers the entire pharmaceutical value chain. From manufacturing medicines to their distribution and promotion, the adeptness of their teams adds value to each step, enabling them to operate efficiently throughout the entire lifecycle of a drug.

A Culture of Commitment

For FRATER RAZES, community’s well-being and comfort are not just important considerations but fundamental duties. Rooted in the company’s philosophy and faith, the commitment to bettering society is a guiding principle that infuses the organization’s engagements with the community.

Minister of the Interior Recognizes FRATER RAZES’ Pivotal Role in Advancing Medical Innovation and National Prosperity

In a landmark event that echoes Algeria’s unwavering commitment to the pharmaceutical sector, Brahim Merad, the Minister of the Interior, Local Assemblies, and Urban Planning, presented FRATER RAZES with investment certificates in a ceremony attended by esteemed dignitaries. The event, graced by the presence of the Wali of Algeria and the President of the People’s Provincial Assembly, stands as a resounding testament to Algeria’s progress in the pharmaceutical realm.

The gala took place at the cutting-edge laboratories of FRATER RAZES, underscoring the nation’s resolute efforts to nurture growth within the pharmaceutical landscape. The Managing Director of FRATER RAZES, Mr. El Hassan Chadi, conveyed his elation at hosting the distinguished delegation and accentuated the pivotal role that pharmaceutical industries occupy in national development.

Mr. El Hassan Chadi remarked, “We are truly honored to extend a warm welcome to the Minister of the Interior, the Wali of Algeria, and the esteemed delegation on this momentous occasion of presenting investment certificates. This recognition underscores the paramount importance that Algerian authorities attribute to the pharmaceutical sector – a sector pivotal in enhancing public health and driving the nation’s economic prosperity.”

FRATER RAZES, an avant-garde pharmaceutical enterprise, has consistently led the way in medical innovations across Algeria. The laboratories have consistently showcased their unwavering dedication to environmental preservation and community well-being. Amira Ben Karah Moustapha, the Director of Sales and Marketing at FRATER RAZES, reiterated the company’s commitment to eco-friendly practices.

“At FRATER RAZES, we place an immense emphasis on sustainable and eco-conscious practices,” Amira Ben Kara Moustafa affirmed. “Our privilege lies in championing environmental preservation while concurrently crafting top-tier pharmaceutical solutions that cater to the needs of our citizens.”

The investment certificates bestowed upon FRATER RAZES reassert the Algerian government’s unwavering confidence in the pharmaceutical sector’s potential and the company’s pivotal role in steering medical progress within the nation. This recognition serves as an added impetus for FRATER RAZES to amplify its research and development initiatives, thus fostering a robust ecosystem conducive to healthcare innovation in Algeria.

Brahim Merad, the Minister of the Interior, lauded FRATER RAZES’ accomplishments and reaffirmed the company’s position as a source of national pride. He underscored the government’s steadfast commitment to supporting and investing in industries that champion innovation, sustainability, and the well-being of Algerian citizens.

Pioneering Excellence and Regional Impact: FRATER RAZES Shaping Algeria’s Pharmaceutical Landscape

As FRATER RAZES continues to shape Algeria’s pharmaceutical industry, its dedication to excellence, adherence to rigorous quality standards, and commitment to community welfare remain at the forefront of its endeavors. The legacy of pioneering pharmaceutical solutions and making a positive impact on society drives FRATER RAZES forward as a true pioneer in Algeria’s pharmaceutical landscape.

The success of the FRATER RAZES laboratory dovetails with Algeria’ strategic initiatives aimed at diversifying exports beyond hydrocarbons and curbing the import bill. The laboratory’s footprint extends to 10 African countries and three Arab nations, illustrating its regional prominence and contribution to advancing healthcare solutions across borders.

In a time when the world faced unprecedented challenges, the FRATER RAZES laboratory not only met them head-on but excelled, setting a precedent for innovation, self-reliance, and collaborative progress in the Algerian pharmaceutical landscape.